跳至主要内容
临床试验/ACTRN12611000199910
ACTRN12611000199910已完成4 期

A randomised placebo controlled trial to assess the effects of therapy with cholecalciferol on biochemical, bone and patient-level outcomes in patients undergoing haemodialysis (chronic kidney disease stage 5D; CKD 5D)

Westmead Hospital, Sydney West Area Health Service0 个研究点目标入组 62 人开始时间: 2011年2月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients on satellite haemodialysis for over 12 weeks with levels of 25-hydroxyvitamin D <60 nmol/L.

排除标准

  • Patients who have undergone parathyroidectomy within 3 months or who require treatment with cinacalcet HCl, patients with hypercalcaemia (corected serum calcium > 2.6 mmol/L), or patients who are on treatment with bisphosphonates, or who have unstable medical conditions or are scheduled for major surgery.

研究者

发起方
Westmead Hospital, Sydney West Area Health Service

相似试验

Does cholecalciferol (vitamin D3) improve... | 临床试验